A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

NCT07219043 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Microvascular Inflammation

Interventions

DRUG: Felzartamab
DRUG: Placebo

Sponsor

Biogen